Repetitive transcranial magnetic stimulation as treatment for depression in Parkinson's disease

Movement Disorders

Volumn 25, Issue 14, 2010, Pages 2272-2273

  Chen, Robert ^a  

^a UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO;

CLINICAL TRIAL; DEPRESSION; EDITORIAL; HUMAN; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; PARKINSON DISEASE; PREFRONTAL CORTEX; PRIORITY JOURNAL; THERAPY RESISTANCE; TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT OUTCOME;

DEPRESSION; HUMANS; PARKINSON DISEASE; PREFRONTAL CORTEX; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 77958549250     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23266     Document Type: Editorial

References (14)

1. Lang AE, Obeso JA. Challenges in Parkinson's disease: restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 2004; 3: 309-316.
2. Chaudhuri KR, Healy DG, Schapira AH. Non-motor symptoms of Parkinson's disease: diagnosis and management. Lancet Neurol 2006; 5: 235-245.
3. Lemke MR, Fuchs G, Gemende I, et al. Depression and Parkinson's disease. J Neurol 2004; 251 Suppl. 6: VI/24-VI/27.
4. Veazey C, Aki SO, Cook KF, Lai EC, Kunik ME. Prevalence and treatment of depression in Parkinson's disease. J Neuropsychiatry Clin Neurosci 2005; 17: 310-323.
5. Miller KM, Okun MS, Fernandez HF, Jacobson CE, Rodriguez RL, Bowers D. Depression symptoms in movement disorders: comparing Parkinson's disease, dystonia, and essential tremor. Mov Disord 2007; 22: 666-672.
6. Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009; 120: 2008-2039.
7. Pascual-Leone A, Valls-Solé J, Wassermann EM, Hallett M. Responses to rapid-rate transcranial magnetic stimulation of the human motor cortex. Brain 1994; 117: 847-858.
8. Chen R, Classen J, Gerloff C, et al. Depression of motor cortex excitability by low-frequency transcranial magnetic stimulation. Neurology 1997; 48: 1389-1403.
9. Fregni F, Simon DK, Wu A, Pascual-Leone A. Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature. J Neurol Neurosurg Psychiatry 2005; 76: 1614-1623.
10. Elahi B, Elahi B, Chen R. Effect of transcranial magnetic stimulation on Parkinson motor function-systematic review of controlled clinical trials. Mov Disord 2009; 24: 357-363.
11. Pal E, Nagy F, Aschermann Z, Balazs E, Kovacs N. The impact of left prefrontal repetitive transcranial magnetic stimulation on depression in Parkinson' disease: a randomized, double-blinded, placebo-controlled study. Mov Disord (in press).
12. Fregni F, Santos CM, Myczkowski ML, et al. Repetitive transcranial magnetic stimulation is as effective as fluoxetine in the treatment of depression in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 2004; 75: 1171-1174.
13. O'reardon JP, Solvason HB, Janicak PG, et al. Efficacy and safety of transcranial magnetic stimulation in the acute treatment of major depression: a multisite randomized controlled trial. Biol Psychiatry 2007; 62: 1208-1216.
14. Epstein CM, Evatt ML, Funk A, et al. An open study of repetitive transcranial magnetic stimulation in treatment-resistant depression with Parkinson's disease. Clin Neurophysiol 2007; 118: 2189-2194.